Cardiovascular Outcome Trials with Glucose-Lowering Drugs

被引：0
|
作者：
Tina K. Thethi
Anika Bilal
Richard E. Pratley
机构：
[1] AdventHealth Translational Research Institute,
[2] AdventHealth Diabetes Institute,undefined
来源：
Current Cardiology Reports | 2021年 / 23卷
关键词：
Cardiovascular outcome trials; Thiazolidinediones, Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptors agonists; Sodium-glucose cotransporter 2 inhibitors; Insulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Glucose-Lowering Medications and Cardiovascular Outcomes
    Madhan Shanmugasundaram
    J. R. Exequiel Pineda
    Sangeetha Murugapandian
    Current Cardiology Reports, 2021, 23
  • [32] Glucose-Lowering Medications and Cardiovascular Outcomes
    Shanmugasundaram, Madhan
    Pineda, J. R. Exequiel
    Murugapandian, Sangeetha
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (04)
  • [33] Representation of people of South Asian origin in cardiovascular outcome trials of glucose-lowering therapies in Type 2 diabetes
    Khunti, K.
    Bellary, S.
    Karamat, M. A.
    Patel, K.
    Patel, V.
    Jones, A.
    Gray, J.
    Shepherd, P.
    Hanif, W.
    DIABETIC MEDICINE, 2017, 34 (01) : 64 - 68
  • [34] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (11) : 1267 - 1271
  • [35] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes REPLY
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 671 - 672
  • [36] Influence of Telmisartan on the Metabolism of Glucose-Lowering Drugs
    Li, Jian-Hui
    LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (03): : 484 - 488
  • [37] Perioperative Management of Glucose-lowering Drugs: Comment
    Thiruvenkatarajan, Venkatesan
    Jesudason, David
    Nanjappa, Nagesh
    Meyer, Emily Jane
    Van Wijk, Roelof M.
    ANESTHESIOLOGY, 2021, 134 (02) : 349 - 350
  • [38] Glucose-lowering drugs: balancing risks and benefits
    不详
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09): : 669 - 669
  • [39] Perioperative Management of Glucose-lowering Drugs: Reply
    Preiser, Jean-Charles
    Cnop, Miriam
    ANESTHESIOLOGY, 2021, 134 (02) : 350 - 351
  • [40] Newer glucose-lowering drugs and risk of suicidal ideation and behaviours: A network meta-analysis of randomized outcome trials
    Lu, Ying
    Tang, Huilin
    Kotecha, Pareeta
    Cho, Hwayoung
    Donahoo, William T.
    Bian, Jiang
    Guo, Jingchuan
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4783 - 4786
12345